Drug Type Small molecule drug |
Synonyms Guaifenesin/Hydrocodone Tartrate/Pseudoephedrine Hydrochloride, Guaifenesin/hydrocodone/pseudoephedrine, Hycofenix |
Mechanism Opioid receptors agonists(Opioid receptors agonists), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date US (14 May 2015), |
Regulation- |
Molecular FormulaC22H29NO10 |
InChIKeyZICRJLQTAUVSDU-NSJZFRMTSA-N |
CAS Registry34195-34-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Common Cold | Phase 2 | CN | 22 Jun 2013 | |
Common Cold | Phase 2 | CN | 22 Jun 2013 | |
Influenza, Human | Phase 2 | CN | 22 Jun 2013 | |
Influenza, Human | Phase 2 | CN | 22 Jun 2013 | |
Sinusitis | Phase 2 | CN | 22 Jun 2013 | |
Bronchitis | Discovery | CN | 22 Jun 2013 | |
Bronchitis | Discovery | CN | 22 Jun 2013 | |
Sinusitis | Discovery | CN | 22 Jun 2013 |